VentriPoint Diagnostics Ltd. (CVE:VPT – Get Free Report) shares rose 19.4% on Friday . The stock traded as high as C$0.20 and last traded at C$0.19. Approximately 786,575 shares were traded during mid-day trading, an increase of 171% from the average daily volume of 290,653 shares. The stock had previously closed at C$0.16.
VentriPoint Diagnostics Price Performance
The company has a market cap of C$30.01 million, a P/E ratio of -5.72 and a beta of 0.39. The firm’s 50-day moving average is C$0.10 and its two-hundred day moving average is C$0.13. The company has a debt-to-equity ratio of -58.56, a current ratio of 0.28 and a quick ratio of 6.67.
About VentriPoint Diagnostics
Ventripoint Diagnostics Ltd., a medical device company, engages in the development and commercialization of diagnostic tools that monitor patients with heart disease worldwide. It offers Ventripoint Medical System (VMS), a medical imaging system that is used to generate three-dimensional models with critical volume and functional measurements of a patient’s heart chambers.
Further Reading
- Five stocks we like better than VentriPoint Diagnostics
- Dividend King Proctor & Gamble Is A Buy On Post-Earnings Weakness
- Is Myers Industries Poised for a Breakout?
- Most Volatile Stocks, What Investors Need to Know
- Is BigBear.ai’s 25% Plunge a False Alarm or Fire Sale?
- How to Invest in Blue Chip Stocks
- Broadcom Confirmed Its AI Outlook: Stock to Hit New Highs Soon
Receive News & Ratings for VentriPoint Diagnostics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for VentriPoint Diagnostics and related companies with MarketBeat.com's FREE daily email newsletter.
